Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer

Author: Bothwell Katelyn D.   Folaron Margaret   Seshadri Mukund  

Publisher: MDPI

E-ISSN: 2072-6694|8|1|11-11

ISSN: 2072-6694

Source: Cancers, Vol.8, Iss.1, 2016-01, pp. : 11-11

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract